Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
6 hedge funds and large institutions have $4.04M invested in Forward Pharma A/S American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
9% less capital invested
Capital invested by funds: $4.45M → $4.04M (-$406K)
25% less funds holding
Funds holding: 8 → 6 (-2)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Mason Capital Management
New York
|
+$485K |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$431K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$53.2K |
| 2 |
Citigroup
New York
|
-$19K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$5.32K |
| 4 |
Morgan Stanley
New York
|
-$4.36K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $2.23M | +$431K | +80,899 | +19% |
|
|
2
Morgan Stanley
New York
| $822K | -$4.36K | -819 | -0.4% |
|
|
MCM
3
Mason Capital Management
New York
| $653K | +$485K | +91,076 | +154% |
|
4
Acadian Asset Management
Boston,
Massachusetts
| $277K | – | – | – |
|
|
5
Renaissance Technologies
New York
| $65K | -$53.2K | -10,000 | -41% |
|
|
6
Citigroup
New York
| – | -$19K | -3,187 | Closed |
|
|
7
Osaic Holdings
Scottsdale,
Arizona
| – | -$5.32K | -1,000 | -100% |
|
FWP Hedge Fund Activity: Q2 2022 in Review
6 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q2 2022, worth a combined $4.04M — down 9.1% from $4.45M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of FWP and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Mason Capital Management, adding an estimated $485K. The largest seller was Renaissance Technologies, cutting an estimated $53.2K.
- 6 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q2 2022, down from 8 in Q1 2022.
- Funds reported $4.04M of Forward Pharma A/S American Depositary Shares stock for Q2 2022, down 9.1% quarter-over-quarter.
- 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q2 2022 and 2 closed out, a net change of -2 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q2 2022 was Mason Capital Management, an estimated $485K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q2 2022 was Renaissance Technologies, an estimated $53.2K sold.
Based on aggregated 13F filings for Q2 2022.